Rikard Holmdahl

Rikard Holmdahl

Professor | Professor, Senior | Docent
Telephone: +46852484607
Visiting address: Solnavägen 9, 9D, 17177 Stockholm
Postal address: C2 Medicinsk biokemi och biofysik, C2 Immunologi Holmdahl, 171 77 Stockholm

About me

  • I have an unusual background as I entered medical school on the basis of several years work in hard metal industry. I studied on evenings and succeed to be accepted at medical school at Uppsala University 1977. During the medical courses I became interested in basic research and in particular in immunology and why autoimmune diseases developed. I joined the immunology department led by Hans Wigzell 1981 and completed my PhD 1985. I completed my MD 1987 and was appointed as a docent 1987, everything at Uppsala University. After a short clinical residency career, and some shorter postdoc experiences in US, I was appointed as an associate professor at the Swedish Medical Research Council 1990. I was appointed as a full professor at Lund University 1993 and, happily for me, my entire research group joined in the move to Lund – together we formed the Medical Inflammation Research (MIR) unit at Lund University.

    At Lund University we built a platform for genetic analysis of animal models for autoimmune diseases. We were the first to positionally clone genetic polymorphism causing autoimmune diseases, the first discovery was a single nucleotide polymorphism at the Ncf1 gene causing susceptibility to autoimmune diseases in rat models. This polymorphism could later be shown to of major importance also in human autoimmune diseases and contributed to change the view on redox regulation, lack of oxidation could enhance autoimmunity. We have continued to positional clone genes and our current research is based on several of the genes that have been identified, making the focus on relevant targets for regulation of autoimmune diseases more relevant.

    In 2008 I was recruited to Karolinska Institute and was located as a professor and head of the section for medial inflammation research. We moved our research group from Lund to Stockholm. On the basis of our basic research we continued to also develop some more applied projects with the aim to enhance the diagnostic tests and developing vaccines to prevent autoimmune diseases. We have continued our genetic research with a strong focus on redox regulation in autoimmunity but we are also looking at the other side of the coin, how redox regulation could help protection against cancer.

    To be research leader also requires administrative and economic responsibilities as all research need to be self-financed and be adjusted into a university organisation. Besides this, its and important scientific responsibility, also at the international level, to defend scientific standards. But the beauty of science is still very strongly alive for me, to have the golden opportunity to make new discoveries and discuss research results with my younger coworkers and collegues.

    Ranked no 2 in Sweden in Immunology (2022 edition for the ranking of top 1000 scientists) and no 245 in the world.

Selected publications

Articles

All other publications

Grants

Employments

  • Professor, Senior, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2025-2025
  • Professor, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2009-2024
  • Professor, Lund University, 1994-2008

Degrees and Education

  • Docent, Med fak, Uppsala Universitet., 1987
  • MD, Uppsala University Hospital, 1987
  • PhD, Medical Biochemistry, Uppsala University, 1985

News from KI

Events from KI